statistiche ricercatore

Continente	#
NA - Nord America	674
AS - Asia	572
EU - Europa	302
SA - Sud America	75
AF - Africa	35
Continente sconosciuto - Info sul continente non disponibili	2
Totale	1.660

Nazione	#
US - Stati Uniti d'America	659
SG - Singapore	208
CN - Cina	168
VN - Vietnam	90
SE - Svezia	78
IE - Irlanda	66
BR - Brasile	61
DE - Germania	42
HK - Hong Kong	32
FI - Finlandia	21
ZA - Sudafrica	19
FR - Francia	18
IN - India	16
NL - Olanda	16
TR - Turchia	16
CI - Costa d'Avorio	12
GB - Regno Unito	11
CA - Canada	10
IQ - Iraq	10
IT - Italia	10
RU - Federazione Russa	9
EC - Ecuador	7
PL - Polonia	6
BE - Belgio	5
LT - Lituania	5
PK - Pakistan	5
AR - Argentina	4
BD - Bangladesh	4
IR - Iran	4
AT - Austria	3
ID - Indonesia	3
MX - Messico	3
PH - Filippine	3
CZ - Repubblica Ceca	2
ES - Italia	2
EU - Europa	2
JP - Giappone	2
LV - Lettonia	2
PY - Paraguay	2
UZ - Uzbekistan	2
AZ - Azerbaigian	1
BB - Barbados	1
BH - Bahrain	1
CG - Congo	1
CL - Cile	1
DZ - Algeria	1
GE - Georgia	1
HU - Ungheria	1
IL - Israele	1
KE - Kenya	1
MD - Moldavia	1
MU - Mauritius	1
MY - Malesia	1
NO - Norvegia	1
NP - Nepal	1
PA - Panama	1
PT - Portogallo	1
RO - Romania	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TW - Taiwan	1
Totale	1.660

Nome	#
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor?	166
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD)	162
Gastro panel® for detection of atrophic gastritis: The “Parma model”	146
Serum pepsinogen II for early assessment of success of H. pylori eradication	144
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status	141
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES	136
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION	135
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE	135
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR?	132
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL”	131
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD)	130
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy	114
Totale	1.672

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	4	0	0	0	0	0	0	0	0	0	3	1	0
2021/2022	69	0	0	0	4	8	2	1	4	2	7	15	26
2022/2023	317	26	37	31	30	27	36	1	28	88	1	11	1
2023/2024	100	2	12	2	3	6	24	9	7	6	8	10	11
2024/2025	367	21	13	17	21	43	38	1	15	58	30	35	75
2025/2026	630	90	41	50	75	113	48	47	19	89	58	0	0
Totale													1.672